Jounce Therapeutics Inc. (JNCE)
NASDAQ: JNCE
· Real-Time Price · USD
1.88
0.00 (0.00%)
At close: May 03, 2023, 10:00 PM
Jounce Therapeutics Revenue
Jounce Therapeutics reported an annual revenue of $82M, reflecting a 204.75% growth. For the quarter ending December 31, 2022, Jounce Therapeutics generated $82M in revenue.
Revenue (ttm)
82M
Revenue Growth
204.75%
Price / Sales Ratio
0.7
Revenue / Employee
581.56K
Employees
141
Market Cap
98.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 82M | +204.75% |
| Dec 31, 2021 | 26.91M | -56.84% |
| Dec 31, 2020 | 62.34M | -57.84% |
| Dec 31, 2019 | 147.87M | +126.79% |
| Dec 31, 2018 | 65.2M | -8.99% |
| Dec 31, 2017 | 71.64M | +92.61% |
| Dec 31, 2016 | 37.2M | +Infinity% |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |